Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.6200
-0.0975 (-13.59%)
At close: Apr 1, 2025, 4:00 PM
0.6490
+0.0290 (4.68%)
After-hours: Apr 1, 2025, 7:47 PM EDT

Vor Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
77138153437433-
Upgrade
Market Cap Growth
-9.38%-9.38%-65.05%0.75%--
Upgrade
Enterprise Value
1710829341225-
Upgrade
Last Close Price
0.621.112.256.6511.62-
Upgrade
PB Ratio
0.801.431.011.742.00-
Upgrade
P/TBV Ratio
1.431.431.011.742.00-
Upgrade
Debt / Equity Ratio
0.330.330.240.160.080.38
Upgrade
Quick Ratio
4.944.948.8117.5520.434.76
Upgrade
Current Ratio
5.195.199.0418.0621.124.81
Upgrade
Return on Equity (ROE)
-94.52%-94.52%-58.74%-39.45%-52.09%-155.02%
Upgrade
Return on Assets (ROA)
-44.42%-44.42%-31.67%-21.55%-27.09%-63.23%
Upgrade
Return on Capital (ROIC)
-48.11%-48.11%-33.10%-22.29%-28.68%-73.05%
Upgrade
Earnings Yield
-151.04%-84.57%-77.25%-21.09%-15.90%-
Upgrade
FCF Yield
-129.04%-72.25%-66.44%-21.44%-16.86%-
Upgrade
Buyback Yield / Dilution
-2.25%-2.25%-69.88%-18.30%-15548.01%-85.85%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q